Claims to question
Pause when the answers turn into slogans.
Ask for names, records and written terms. The look of a service’s website cannot supply those answers.
A prescription is not an optional extra
Dispensing a prescription medicine requires a prescription from a licensed practitioner under federal law checked September 26, 2026.
An offer to skip that step is a warning sign identified by FDA, the US agency that reviews medicines.
Ask who will assess you before any medicine is supplied.
Watch for borrowed approval language
On September 26, 2026, medicines compounded to order lacked approval from FDA.
FDA calls it false or misleading to present a compounded medicine as approved or equivalent to an approved drug.
Ask for the exact product record when an ad blurs those terms.
Find out who actually made it
By September 26, 2026, FDA had recorded fake labels on compounded semaglutide and tirzepatide. These labels gave names of nonexistent pharmacies.
Other false labels used real pharmacy names even though the named pharmacy had not made the medicine.
Get the maker’s full name and check it through the relevant board before relying on the label.
Use the people-and-permits checkA research label does not make a drug suitable
In its guidance checked September 26, 2026, FDA urged consumers to avoid research-labelled weight-care products sold for human use.
Their quality has not been established, and they could cause harm.
Ask who will check your health, write the prescription and supply the medicine. Request the full pharmacy name and use it to check the pharmacy.
A cheap price cannot settle legitimacy
FDA identifies implausibly deep discounts as a warning sign. A cheap price by itself does not prove something is wrong.
Look at it alongside the prescription, licence and product checks.
Ask what is included and what the later bill will be.